Karla Fernanda Arevalo Gomez

PhD Student

Karla Arévalo received her medical degree from the Universidad Nacional Autonoma de Mexico (UNAM) (2016), Mexico and within International Master in Innovative Medicine (IMIM) from the University of Heidelberg, University of Groningen, and Uppsala University, the master degrees in Translational Medicine (2017) and Medical and Pharmaceutical Drug Innovation (2018). In September 2018, Karla started working as a PhD candidate under supervision of prof. Van der Meer and co-supervised by Dr. Martijn Hoes and Dr. Jasper Tromp at the Experimental Cardiology department of the University Medical Center Groningen (UMCG).

Current activities

Her study will elucidate the differences between diabetic patients with and without heart failure by assessing patient specific mRNA targets and determining the mechanistic implications of identified targets in vitro (stem cell derived cardiomyocytes) and in vivo.

My projects


Facilitate personalized therapies in patients with heart failure


Stem cell models to unravel the susceptibility and resilience to develop heart failure

My publications

Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism

Martijn F. Hoes, Nils Bomer, Melanie Ricke-Hoch, Tristan V. de Jong, Karla F. Arevalo Gomez, Stefan Pietzsch, Denise Hilfiker-Kleiner, Peter van der Meer. Circulation, 2020

view on publisher site

An RNAi Screen Reveals an Essential Role for HIPK4 in Human Skin Epithelial Differentiation from iPSCs.

Larribère, L., Galach, M., Novak, D., Arévalo, K., Volz, H. C., Stark, H. J., … Utikal, J. Stem cell reports. 2017

view on publisher site